# Plexresearch > Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04. - **Business Profile:** https://optimly.ai/brand/plexresearch - **Dataset:** https://optimly.ai/brand/plexresearch.json - **Markdown:** https://optimly.ai/brand/plexresearch/llms.txt - **Official website:** https://plexresearch.com - **Slug:** plexresearch - **Categories:** biotechnology ## Overview - **Tagline:** Plex uses a 'data-first' approach, directly querying structured biomedical databases (genomics, proteomics, clinical trials, compound activity) to deliver evidence-backed, reproducible answers with full source traceability, distinguishing itself from literature-based LLMs that search text and may generate unverifiable answers. Source: Brand's website (https://plexresearch.com) · 2026-10-04 - **Description:** Plexresearch is a scientific intelligence platform that leverages a massive biomedical knowledge graph, 'Focal Graph', to transform how pharmaceutical and biotech teams discover targets, evaluate programs, and make critical R&D decisions. It provides evidence-backed insights by querying structured biomedical data (genomics, proteomics, compound activity, clinical trials) rather than relying on literature-based AI guesswork, aiming to accelerate the discovery of cures. Source: Brand's website (https://plexresearch.com) · 2026-10-04 ## Offerings - **Core capabilities:** - Plex Scientific Intelligence Platform - featuring the Focal Graph knowledge graph for querying billions of biomedical data points. Source: Brand's website (https://plexresearch.com) · 2026-10-04 - **Pricing:** Not specified (demonstration and free reports available suggest an enterprise/subscription model). Source: Brand's website (https://plexresearch.com) · 2026-10-04 ## Audience - **Target industry:** Pharmaceutical and biotech discovery teams, scientists, computational developers, and executives in the life sciences sector. Source: Brand's website (https://plexresearch.com) · 2026-10-04 Page last updated 2026-10-17.